This investigation is interested in exploring how a single essential amino acid, specifically L-tryptophan, affects protein metabolism in the liver. In earlier reports from our laboratory, we have described that L-tryptophan rapidly stimulates hepatic polyribosomal aggregation and protein synthesis. This effect appears to be related to alterations in both transcriptional and posttranscriptional controls. Earlier studies at the cellular and subcellular levels have revealed that L-tryptophan acts on the hepatic nucleus (nuclear membrane) to stimulate enhanced nucleocytoplasmic translocation of mRNA Recent findings have demonstrated that there is a specific tryptophan-binding site on the nuclear envelopes of rat liver. This 64 kDa glycoprotein receptor for L-tryptophan has been purified and characterized. We plan to further characterize (composition, active structure and function) the 64 kDa glycoprotein purified as the hepatic nuclear envelope tryptophan binding protein. This will be conducted using purified rat hepatic nuclear envelope tryptophan binding protein as well as using cloned fusion protein. Since tryptophan rapidly stimulates hepatic nuclear poly(A)polymerase activity and since we have determined a close association between this enzyme and the tryptophan receptor protein, we plan to define the relationship between the two. We consider the receptor binding of tryptophan and the enhancement of poly(A)polymerase activity due to tryptophan to be important and vital components in the tryptophan-induced stimulation of hepatic protein synthesis. Such information may offer basic insight as to how an important dietary component, as exemplified by L-tryptophan, may play a regulatory role in mammalian liver protein metabolism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK045353-02
Application #
3246868
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1992-09-30
Project End
1995-09-29
Budget Start
1993-09-30
Budget End
1994-09-29
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
George Washington University
Department
Type
Schools of Medicine
DUNS #
City
Washington
State
DC
Country
United States
Zip Code
20052
Burguera, B; Proctor, D; Dietz, N et al. (2000) Leg free fatty acid kinetics during exercise in men and women. Am J Physiol Endocrinol Metab 278:E113-7
Nielsen, S; Hensrud, D D; Romanski, S et al. (2000) Body composition and resting energy expenditure in humans: role of fat, fat-free mass and extracellular fluid. Int J Obes Relat Metab Disord 24:1153-7
Sidransky, H (1997) Tryptophan and carcinogenesis: review and update on how tryptophan may act. Nutr Cancer 29:181-94
Sidransky, H; Verney, E (1997) Differences in tryptophan binding to hepatic nuclei of NZBWF1 and Swiss mice: insight into mechanism of tryptophan's effects. J Nutr 127:270-5
Sidransky, H; Verney, E (1997) Mouse strain and source of L-tryptophan affects hepatic nuclear tryptophan binding. Toxicology 118:37-47
Sidransky, H; Verney, E; Latham, P et al. (1996) Effects of tryptophan related compounds on nuclear regulatory control. Possible role in the eosinophilia-myalgia syndrome. Adv Exp Med Biol 398:343-50
Jensen, M D; Johnson, C M (1996) Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive FFA flux in men and women. Metabolism 45:662-6
Sidransky, H; Verney, E (1996) Toxic effect of valproic acid on tryptophan binding to rat hepatic nuclei. Toxicology 109:39-47
Sidransky, H; Verney, E; Cosgrove, J W et al. (1994) Indolic compounds affect tryptophan binding to rat hepatic nuclei. J Nutr 124:779-88
Sidransky, H (1994) Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead. Mod Pathol 7:806-10

Showing the most recent 10 out of 11 publications